Longitudinal prediction of falls and near falls frequencies in Parkinson’s disease: a prospective cohort study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1459
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Longitudinal prediction of falls and near falls frequencies in Parkinson’s disease: a prospective cohort study ; day:24 ; month:9 ; year:2020 ; pages:1-9
Journal of neurology ; (24.9.2020), 1-9
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00415-020-10234-6
- URN
-
urn:nbn:de:101:1-2020111220253870369214
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:19 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lindholm, Beata
- Brogårdh, Christina
- Odin, Per
- Hagell, Peter
- SpringerLink (Online service)
Other Objects (12)
Development of a Parkinson’s disease specific falls questionnaire
Longitudinal evaluation of polyneuropathy in Parkinson’s disease
Falls risk is predictive of dysphagia in Parkinson’s disease
Fall-related activity avoidance in relation to a history of falls or near falls, fear of falling and disease severity in people with Parkinson’s disease
Parkinson’s Disease and Dementia: A Longitudinal Study (DEMPARK)
Longitudinal Studies of Sleep Disturbances in Parkinson’s Disease
Prognostic factors for falls in Parkinson’s disease: a systematic review
An exercise intervention to prevent falls in Parkinson’s: an economic evaluation
Digitomotography in Parkinson’s Disease: A Cross-Sectional and Longitudinal Study
Development and Validation of a Fall Questionnaire for Patients with Parkinson’s Disease
Cholinesterase inhibitor to prevent falls in Parkinson’s disease (CHIEF-PD) trial: a phase 3 randomised, double-blind placebo-controlled trial of rivastigmine to prevent falls in Parkinson’s disease
Longitudinal trimodal imaging of midbrain-associated network degeneration in Parkinson’s disease
Development of a Parkinson’s disease specific falls questionnaire
Longitudinal evaluation of polyneuropathy in Parkinson’s disease
Falls risk is predictive of dysphagia in Parkinson’s disease
Fall-related activity avoidance in relation to a history of falls or near falls, fear of falling and disease severity in people with Parkinson’s disease
Parkinson’s Disease and Dementia: A Longitudinal Study (DEMPARK)
Longitudinal Studies of Sleep Disturbances in Parkinson’s Disease
Prognostic factors for falls in Parkinson’s disease: a systematic review
An exercise intervention to prevent falls in Parkinson’s: an economic evaluation
Digitomotography in Parkinson’s Disease: A Cross-Sectional and Longitudinal Study
Development and Validation of a Fall Questionnaire for Patients with Parkinson’s Disease
Cholinesterase inhibitor to prevent falls in Parkinson’s disease (CHIEF-PD) trial: a phase 3 randomised, double-blind placebo-controlled trial of rivastigmine to prevent falls in Parkinson’s disease
Longitudinal trimodal imaging of midbrain-associated network degeneration in Parkinson’s disease
Development of a Parkinson’s disease specific falls questionnaire
Longitudinal evaluation of polyneuropathy in Parkinson’s disease
Falls risk is predictive of dysphagia in Parkinson’s disease
Fall-related activity avoidance in relation to a history of falls or near falls, fear of falling and disease severity in people with Parkinson’s disease
Parkinson’s Disease and Dementia: A Longitudinal Study (DEMPARK)
Longitudinal Studies of Sleep Disturbances in Parkinson’s Disease
Prognostic factors for falls in Parkinson’s disease: a systematic review
An exercise intervention to prevent falls in Parkinson’s: an economic evaluation
Digitomotography in Parkinson’s Disease: A Cross-Sectional and Longitudinal Study
Development and Validation of a Fall Questionnaire for Patients with Parkinson’s Disease
Cholinesterase inhibitor to prevent falls in Parkinson’s disease (CHIEF-PD) trial: a phase 3 randomised, double-blind placebo-controlled trial of rivastigmine to prevent falls in Parkinson’s disease